Current through Register Vol. 47, No. 12, March 26, 2025
(a) A
horse shall have raced in violation of this section if any of the following
substances is found, by the laboratory conducting tests for the commission, to
be present in a race-day urine or blood sample taken from such horse at a
concentration in excess of a threshold listed below. The test result of such
laboratory shall include an assessment of the measurement uncertainty and
imprecision of the quantitative threshold for the substance.
(1) Acepromazine: 10 ng/ml HEPS in
urine;
(2) Albuterol: 1 ng/ml in
urine;
(3) Betamethasone: 10 pg/ml
in plasma;
(4) Butorphanol:
(i) 300 ng/ml of total butorphanol in urine;
or
(ii) 2 ng/ml of free butorphanol
in plasma;
(5)
Cetirizine: 6 ng/ml in plasma;
(6)
Cimetidine: 400 ng/ml in plasma;
(7) Clenbuterol:
(i) 140 pg/ml in urine; or
(ii) any clenbuterol in plasma;
(8) Cobalt: 50 ng/ml in
plasma;
(9) Dantrolene: 100 pg/ml
of 5-hydroxydantrolene in plasma;
(10) Detomidine:
(i) 2 ng/ml of any metabolite of detomidine
in urine; or
(ii) 1 ng/ml of
detomidine in plasma;
(11) Dexamethasone: 5 pg/ml in
plasma;
(12) Diclofenac: 5 ng/ml in
plasma;
(13) DMSO: 10 mcg/ml in
plasma;
(14) Firocoxib: 20 ng/ml in
plasma;
(15) Flunixin: 5 ng/ml in
plasma;
(16) Furosemide: 100 ng/ml
in plasma and a specific gravity of urine less than 1.010;
(17) Glycopyrrolate: 3 pg/ml in
plasma;
(18) Guaifenesin: 12 ng/ml
in plasma;
(19) Isoflupredone: 100
pg/ml in plasma;
(20) Ketoprofen: 2
ng/ml in plasma;
(21) Lidocaine: 20
pg/ml of total 3-hydroxylidocaine in plasma;
(22) Mepivacaine:
(i) 10 ng/ml of total hydroxymepivacaine in
urine; or
(ii) any
hydroxymepivacaine in plasma;
(23) Methocarbamol: 1 ng/ml in
plasma;
(24) Methylprednisolone:
100 pg/ml in plasma;
(25)
Omeprazole: 10 ng/ml of omeprazole sulfide in plasma;
(26) Phenylbutazone: 0.3 mcg/ml in
plasma;
(27) Prednisolone: 1 ng/ml
in plasma;
(28) Procaine
penicillin: 25 ng/ml of procaine in plasma;
(29) Ranitidine: 40 ng/ml in
plasma;
(30) Triamcinolone
acetonide: 100 pg/ml in plasma; and
(31) Xylazine: 200 pg/ml in plasma.
(b) A laboratory finding that a
horse has not exceeded a threshold set forth in this section shall not
constitute a defense to a violation of any other section of this
Subchapter.
(c) Special provisions.
(1) Cobalt. A person who is found responsible
for a violation of this section for the substance cobalt, when the detected
concentration of cobalt exceeds 300 ng/ml in plasma, shall incur the same
penalty described in paragraph (2) of subdivision (b) of section
4043.12 of this Part.
(2) Corticosteroid joint injection. It shall
not be a violation of this section for the drug betamethasone, isoflupredone or
triamcinolone acetonide when:
(i) the
laboratory positive resulted from an administration that was recorded in the
contemporaneous veterinary records of the horse, reported to the commission in
compliance with subdivision (b) of section
4043.4 of this Part before the
horse raced, and administered to the horse in compliance with subdivision (i)
of section 4043.2 of this Part at least seven
days before the race; and
(ii) the
commission had not previously issued a warning to the trainer that the
commission laboratory reported finding such substance, in a urine or blood
sample collected from any horse trained by such trainer, at a concentration in
excess of the threshold set forth in subdivision (a) of this section.